Intensified concomitant chemoradiotherapy for poor prognosis head and neck cancer (English)
- New search for: Vokes, E. E.
- New search for: Haraf, D. J.
- New search for: Moran, W.
- New search for: Wenig, B.
- New search for: Brachman, D.
- New search for: Rubin, S.
- New search for: McEvilly, J.-M.
- New search for: Luckett, P.
- New search for: Panje, W.-R.
- New search for: Weichselbaum, R.-R.
- New search for: Vokes, E. E.
- New search for: Haraf, D. J.
- New search for: Moran, W.
- New search for: Wenig, B.
- New search for: Brachman, D.
- New search for: Rubin, S.
- New search for: McEvilly, J.-M.
- New search for: Luckett, P.
- New search for: Panje, W.-R.
- New search for: Weichselbaum, R.-R.
- New search for: Banzet, P.
In:
Anticancer chemotherapy; Cancer treatment an update
;
283-287
;
1994
-
ISBN:
- Conference paper / Print
-
Title:Intensified concomitant chemoradiotherapy for poor prognosis head and neck cancer
-
Contributors:Vokes, E. E. ( author ) / Haraf, D. J. ( author ) / Moran, W. ( author ) / Wenig, B. ( author ) / Brachman, D. ( author ) / Rubin, S. ( author ) / McEvilly, J.-M. ( author ) / Luckett, P. ( author ) / Panje, W.-R. ( author ) / Weichselbaum, R.-R. ( author )
-
Conference:International congress; 4th, Anticancer chemotherapy; Cancer treatment an update ; 1993 ; Paris
-
Published in:
-
Publisher:
- New search for: Springer Verlag
-
Publication date:1994-01-01
-
Size:5 pages
-
ISBN:
-
Type of media:Conference paper
-
Type of material:Print
-
Language:English
-
Keywords:
-
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents conference proceedings
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 3
-
The pathogenesis of human cancer metastasisFidler, I. J. et al. | 1994
- 7
-
The role of molecular genetics in medical oncologyFreireich, E. J. et al. | 1994
- 10
-
Cell line-based screening for new anticancer drugsChabner, B. A. / Weinstein, J. N. / Paull, K. D. / Grever, M. R. et al. | 1994
- 17
-
Anti-EGF receptor monoclonal antibodies as potential anti-cancer therapyMendelsohn, J. et al. | 1994
- 19
-
Clinical relevance of drug resistance: Where do we stand now and where are we going to?Linn, S. C. / Giaccone, G. / Pinedo, H. M. et al. | 1994
- 24
-
Mobilization, purification and ex vivo expansion of human peripheral blood progenitor cellsBrugger, W. / Mertelsmann, R. / Kanz, L. et al. | 1994
- 29
-
Fluoropyrimidine cancer chronotherapyHrushesky, W. J. M. / Cope, F. O. et al. | 1994
- 40
-
Chemo-immunotherapy of metastatic malignant melanoma. The Salpetriere Hospital (SOMPS) experienceKhayat, D. / Antoine, E. / Rixe, O. / Tourani, J. M. / Vuillemin, E. / Borel, C. / Benhammouda, A. / Thill, L. / Franks, C. / Auclerc, G. et al. | 1994
- 47
-
Concomitant chemoradiotherapy for solid tumorsVokes, E. E. / Stupp, R. et al. | 1994
- 50
-
Current status of therapy for small cell carcinoma of the lungIhde, D. C. et al. | 1994
- 55
-
Systemic treatment of bladder cancerDirix, L. Y. / van Oosterom, A. T. et al. | 1994
- 62
-
Metastatic breast cancer: current management options and future directionsHortobagyi, G. et al. | 1994
- 66
-
Present and future prospects for the chemotherapy of gliomasLevin, V. et al. | 1994
- 70
-
Neo-Adjuvant chemotherapy in breast cancer. Study of 477 evaluable patients with primary breast cancers treated between 1980 and 1992Weil, M. / Auclerc, G. / Borel, C. / Baillet, F. / Thomas, A. / Soubrane, C. / Housset, M. / Nizri, D. / Rixe, O. / Antoine, E. et al. | 1994
- 79
-
Osteogenic sarcoma: a 15-year experience in treating 287 patients with preoperative chemotherapyRosen, G. / Lowenbraun, S. / Forscher, C. et al. | 1994
- 85
-
Cell cycle regulation and the chemosensitivity of cancer cellsKohn, K. W. / O Connor, P. M. et al. | 1994
- 90
-
Reversal of multidrug resistance of hematologic malignancies with chemosensitizers: laboratory and clinical studiesSalmon, S. E. / Miller, T. P. / List, A. F. / Grogan, T. M. / Dalton, W. S. et al. | 1994
- 98
-
Practical approach to bladder cancerDenis, L. et al. | 1994
- 105
-
Primary chemotherapy for breast cancer: response to preoperative chemotherapy as prognostic factorHortobagyi, G. N. / Buzdar, A. U. / Frye, D. / Singletary, S. E. / Holmes, F. A. / Ames, F. / McNeese, M. D. / Theriault, R. L. et al. | 1994
- 110
-
Breast cancer, cytoprognostic grades and proliferative activity (DNA ploidy, S phase)de Maublanc, M. A. et al. | 1994
- 114
-
Primary chemotherapy in the individualized non-multilating treatment of breast cancerPoisson, R. / Legault, S. / Guevin, R. et al. | 1994
- 120
-
Neo-Adjuvant chemotherapy in 100 patients with locally advanced carcinoma of the breastCoudert, B. / Gabez, P. / Lamaille, C. / De Gislain, C. / Mayer, F. / Fargeot, P. et al. | 1994
- 123
-
Surgical aspects of the conservative treatment of large size breast cancer after primary chemotherapyZurrida, S. / Greco, M. / Galimberti, V. / Veronesi, U. et al. | 1994
- 127
-
Efficacy of a chemotherapy regimen combining Vinorelbine, Epirubicine and Methotrexate (VEM) in locally advanced and metastatic breast cancerVan Praagh, J. / Martineau, N. / Feillel, V. / Cure, H. / Belembaogo, E. / Ravoux, M. A. / Fleury, J. / Deloche, C. / Plagne, R. / Chollet, P. et al. | 1994
- 131
-
Recurrent breast carcinoma after conservative treatment: MRI features and pathologic correlationDao, T.-H. / Campana, F. / Fourquet, A. / Laurent, M. / Asselain, B. / Rahmouni, A. et al. | 1994
- 135
-
Intensive chemotherapy for inflammatory breast cancer: how much clinical value?Chevallier, B. / Couteau, C. / Atlan, D. / Chatikhine, V. / Graic, Y. / Julien, J.-P. / Kunlin, A. / Bastit, P. / Veyret, C. / D Anjou, J. et al. | 1994
- 146
-
A Phase II study of 2-weekly high-dose Epirubicin with r-met-hu G-CSF in advanced breast cancerFountzilas, G. / Skarlos, D. / Giannakakis, T. / Athanasiades, A. / Bafaloukos, D. / Protopsaltis, J. / Beer, M. / Pavlidis, N. / Kosmidis, P. et al. | 1994
- 150
-
Cyclophosphamide, Novantrone, Fluorouracil (CNF) + G-CSF Neo-Adjuvant chemotherapy in operable breast cancerLorusso, V. / De Lena, M. / Brandi, M. / Longo, S. / Berardi, F. / Catino, A. / Sapia, M. G. / Simone, G. / Marzullo, F. / Racanelli, A. et al. | 1994
- 155
-
Adjuvant chemohormonal therapy with Cyclophosphamide, Doxorubicin and 5-Fluorouracil (CAF) with or without medroxyprogesterone acetate (MPA) in node-positive breast cancer patientsHupperets, P. / Wils, J. / Volovics, L. / Schouten, L. / Fickers, M. / Bron, H. / Schouten, H. / Jager, J. / Smeets, J. / de Jong, J. et al. | 1994
- 160
-
Follow-up results of an ECOG study of adjuvant therapy in postmenopausal women with breast cancerFalkson, H. C. / Gray, R. / Wolberg, W. H. / Falkson, G. et al. | 1994
- 163
-
Long-term efficacy and late sequelae of Doxorubicin-containing adjuvant therapy for breast cancer: MD Anderson Cancer Center studiesBuzdar, A. / Hortobagyi, G. / Kau, S. / Holmes, F. / Fraschini, G. / Theriault, R. / McNeese, M. / Singletary, S. et al. | 1994
- 167
-
Taxol in metastatic breast cancer: the MD Anderson Cancer Center experienceHolmes, F. A. / Valero, V. / Walters, R. / Theriault, R. / Booser, D. / Buzdar, A. / Gibbs, H. / Frye, D. / Young, K. / Hortobagyi, G. et al. | 1994
- 172
-
Taxol plus recombinant human granulocyte colony stimulating factor as salvage chemotherapy for metastatic breast cancerSeidman, A. D. / Reichman, B. S. / Crown, J. P. A. / Yao, T.-J. / Currie, V. / Hakes, T. B. / Hudis, C. A. / Gilewski, T. A. / Forsythe, P. / Lepore, J. et al. | 1994
- 179
-
A model for chemosentivity testing using in vitro MTT assay on a human squamous carcinoma tongue cell lineKing, W. K. W. / Lam, P. K. / Li, K. C. A. et al. | 1994
- 185
-
Head and neck cancer treatment: present status and future directionAl-Sarraf, M. et al. | 1994
- 191
-
Chemotherapy (CT) followed by radiotherapy (RT) vs. RT alone in patients with resected and negative margins squamous cell carninoma of the head and neck: Phase III Intergroup StudyAl-Sarraf, M. / Scott, C. B. / Ahmad, K. / Schwade, J. G. / Schuller, D. / Laramore, G. E. / Jacobs, J. et al. | 1994
- 196
-
Neo-Adjuvant infusion Cisplatin, 5-FU and high-dose leucovorin for squamous cell carcinoma of the head and neck (SCCHN): high rates of complete response (CR) and definitive radiotherapy as primary site managementClark, J. / Dreyfuss, A. / Busse, P. / Norris, C. / Lucarini, J. / Rossi, R. / Andersen, J. / Casey, D. / Frei, E. et al. | 1994
- 201
-
Primary (Neo-Adjuvant) combined modality therapy in the management of locally advanced squamous cell carcinoma of the head and neckMantovani, G. / Proto, E. / Contini, L. / Littera, S. / Curreli, L. / Cossu, F. / Puxeddu, P. / Del Giacco, G. S. et al. | 1994
- 207
-
A Phase II trial of induction Cisplatin, 5-FU, Leucovorin and Interferon-alpha-2B (PFL-alpha) followed by concurrent Hydroxyurea, 5-FU and radiation for Stage IV squamous cell cancers of the head and neck (HNC)Kies, M. S. / Haraf, D. J. / Mittal, B. / Athanasiadis, I. / Kozloff, M. / McEvilly, J. / Mick, R. / Moran, W. / Panje, W. / Pelzer, H. et al. | 1994
- 211
-
Induction chemotherapy with Cisplatin (P), 5-Fluorouracil (FU) and Folinic Acid (FA) in locally advanced head and neck cancerFonseca, E. / Cruz, J.-J. / Garcia, J. / Panadero, A. / Sanchez, P. / Gomez, A. / Martin, G. / Garcia, M.-J. / Vallejo, J.-C. et al. | 1994
- 214
-
A randomized study of CDDP and 5-FU as Neo-Adjuvant chemotherapy in head and neck cancer: an interim analysisMartin, M. / Vergnes, L. / Lelievre / Michel-Langlet, P. / Peytral, C. / Mazeron, J.-J. / Malaurie, E. / Peynegre, R. et al. | 1994
- 219
-
Concomitant chemoradiotherapy in locally advanced head and neck cancers: a prospective study of 68 patientsWalter, S. / Hennequin, C. / Brette, M. D. / Leblanc, P. / Cheriff-Cheikh, P. Y. / Espie, M. / Monteil, J.-P. / Marty, M. / Maylin, C. et al. | 1994
- 225
-
Epidermal growth factor receptor in upper aerodigestive tract cancerFormento, J.-L. / Francoual, M. / Dassonville, O. / Santini, J. / Ramaioli, A. / Milano, G. / Schneider, M. / Demard, F. et al. | 1994
- 234
-
Concomitant alpha-Interferon and chemotherapy in advanced squamous cell carcinoma of the head and neckBenasso, M. / Merlano, M. / Blengio, F. / Cavallari, M. / Rosso, R. / Toma, S. et al. | 1994
- 237
-
Thymidylate synthase activity and Folate levels in head and neck squamous cell carcinomasParise, O. / Janot, F. / Luboinski, B. / Verjus, M.-A. / Gouyette, A. / Cabot, G.-G. et al. | 1994
- 243
-
Long term nephrotoxicity of Cisplatinum (CDDP) in manBahmed, Y. / Dechaux, M. / Bassot, V. / Brasnu, D. / Kindermans, C. / Laccourreye, H. / Sachs, C. et al. | 1994
- 248
-
Prognostic factors in head and neck cancer patients included in a program of Neo-Adjuvant chemotherapy and radical radiotherapyCastillo, J. / Gomez, F. / Guerrero, R. / Sanchez, P. / Lopez, I. M. / Cueto, J. / Puche, J.-L. G. et al. | 1994
- 251
-
Induction chemotherapy for larynx preservation in laryngeal and hypopharyngeal cancersDemard, F. / Schneider, M. / Dassonville, O. / Chauvel, P. / Thyss, A. / Santini, J. et al. | 1994
- 257
-
A pilot study of vinorelbine on a weekly schedule in recurrent and/or metastatic squamous cell carcinoma of the head and neckGebbia, V. / Testa, A. / Valenza, R. / Zerillo, G. / Restivo, S. / Ingria, F. / Cannata, G. / Borsellino, N. / Gebbia, N. et al. | 1994
- 260
-
Concomitant radiotherapy and Cisplatin in head and neck cancer: a pilot studyOlmi, P. / Fallai, C. / Chiostrini, C. et al. | 1994
- 263
-
Ifosfamide/Mesna plus Carboplatin as Neo-Adjuvant therapy for stage I-III head and neck cancer. Preliminary reportBruno, M. et al. | 1994
- 267
-
Role of Ifosfamide, Cisplatinum (IC) combination in the metastatic neck nodesPai, V.-R. / Parikh, D.-M. / Mazumdar, A. T. / Rao, R. S. et al. | 1994
- 274
-
Clinical pharmacokinetics of Pure 1 Folinic Acid and Fluorouracil during a phase I-II trial of Fluorouracil biomodulation in head and neck cancer patients. Preliminary dataEtienne, M. C. / Milano, G. / Schneider, M. / Thyss, A. / Dassonville, O. / Bardon, M. / Guillot, T. / Demard, F. et al. | 1994
- 280
-
Long-term follow-up of the patients with recurrent or advanced head and neck cancer who received chemotherapy for palliationInuyama, Y. et al. | 1994
- 283
-
Intensified concomitant chemoradiotherapy for poor prognosis head and neck cancerVokes, E. E. / Haraf, D. J. / Moran, W. / Wenig, B. / Brachman, D. / Rubin, S. / McEvilly, J.-M. / Luckett, P. / Panje, W.-R. / Weichselbaum, R.-R. et al. | 1994
- 288
-
Response to chemotherapy of ulcerative lymphoma of the midfaceCabane, J. / Grange, C. / Lamas, G. / Meyer, B. / Godeau, P. / Imbert, J.-C. et al. | 1994
- 291
-
A multicentric study of the GETTEC (Groupe d'Etudes des Tumeurs de la Tete et du Cou) about 408 clinically complete responders after Neo-Adjuvant chemotherapy for head and neck carcinomasChauvel, P. / Lefebvre, J.-L. / Luboinski, B. / Kantor, G. / Bolla, M. / Andry, G. / Brugere, J. / Pessey, J.-J. / Demard, F. et al. | 1994
- 295
-
Chemotherapy of undifferentiated thyroid cancer (UCT) and sarcoma of the thyroid gland (ST)Kober, F. / Heiss, A. / Neugebauer, B. / Roka, R. et al. | 1994
- 298
-
Retinoid chemoprevention of aerodigestive carcinogenesisHong, W.-K. / Lippman, S.-M. / Benner, S.-E. / Lee, J.-S. et al. | 1994
- 303
-
Definite radiation and concomitant Cisplatin administration in locally advanced head and neck cancerFountzilas, G. / Skarlos, D. / Kosmidis, P. / Samantas, E. / Tzitzikas, J. / Makrantonakis, P. / Pantelakos, P. / Nicolaou, A. / Bacoyiannis, H. / Sinodinou, M. et al. | 1994
- 307
-
Improved survival of patients with advanced squamous cell carcinoma of the head and neck with alternating chemotherapy and radiotherapyBenasso, M. / Corvo, R. / Cavallari, M. / Sanguineti, G. / Margarino, G. / Rosso, R. / Vitale, V. / Merlano, M. / Members of affiliated institutions et al. | 1994
- 311
-
Treatment of patients with cancer of the head and neck or esophagus with carboplatin, 5-FU, Interferon-alpha and interleukin-2Schlappack, O. / Hainz, A. / Berghammer, P. / Grasl, M. / Kautzky, M. / Kment, G. / Dobrowsky, W. / Dittrich, C. et al. | 1994
- 315
-
Surgical considerations in the treatment of well-differentiated thyroid cancerRoisman, I. / Barak, V. / Sapir, D. / Bitterman, A. / Livni, N. / Honigman, J. / Gimmon, Z. / Manny, J. / Durst, A. L. et al. | 1994
- 319
-
Intensive chemotherapy with recombinant-human granulocyte-macrophage colony stimulating factor (r-hu-gm-csf) for small cell lung cancer (sclc): a pilot studyBesana, C. / Bucci, E. / Borri, A. / Di Lucca, G. / Tognella, S. / Tresoldi, M. / Marcatti, M. / Corti, C. / Citterio, G. / Inversi, F. et al. | 1994
- 322
-
Sequential high-dose chemotherapy with r-metHu-G-CSF (Filgrastim) and infusion of peripheral blood progenitor cells (PBPC) in patients with small cell lung cancer (SCLC). A feasibility studyLeyvraz, S. / Ketterer, N. / Grob, J. P. / Schneider, P. / Vuichard, P. / von Fliedner, V. / Lejeune, F. et al. | 1994
- 328
-
Cisplatinum and 5-Fluorouracil in small cell lung cancerMorere, J. F. / Duran, A. / Tcherakian, F. / Boaziz, C. / Battesti, J. P. / Israel, L. / Breau, J. L. et al. | 1994
- 331
-
Phase I-II study of oral Etoposide and modulation of drug resistance with ketoconazole in small cell lung cancerDalley, D. / Brigham, B. et al. | 1994
- 336
-
Angiogenesis: a novel target for Adjuvant chemotherapy in locally advanced non-small cell lung cancerMacchiarini, P. / Fontanini, G. / Dulmet, E. / de Montpreville, V. / Chapelier, A. / Lenot, B. / Cerrina, J. / Le Roy Ladurie, F. / Dartevelle, P. et al. | 1994
- 343
-
A statistical model for investigating Adjuvant chemotherapy in T1N0M0 non-small cell lung cancerHardin, J. M. / Macchiarini, P. / Singh, K. P. et al. | 1994
- 348
-
A combination chemotherapy with Ifosfamide (I), Cisplatin (P) and Etoposide (E) for advanced non-small cell lung cancer (NSCLC)Martin, G. / Garcia, M. J. / Cruz, J. J. / Gomez, A. / Panadero, A. / Fonseca, E. / Sanchez, P. / Soria, P. / Garcia, J. / Vallejo, J. C. et al. | 1994
- 351
-
Mitomycin, Ifosfamide and Platin (MIP) in advanced and disseminated non-small cell lung cancer (NSCLC)Souquet, P. J. / Bohas, C. / Zenone, T. / Michaud, E. / el Khoury, M. T. / Romestaing, P. / Bernard, J. P. et al. | 1994
- 354
-
Phase III randomized study of Neo-Adjuvant chemotherapy surgery in non-small cell lung cancer (NSCLC) preliminary resultsDepierre, A. / Milleron, B. / Chastang, C. / Lebeau, B. / Terrioux, P. / Quoix, E. / Moro, D. / Miech, G. / Paillot, N. / Breton, J. L. et al. | 1994
- 357
-
Vinorelbine, 5-Fluorouracil, Folinic acid and Cisplatin in non-small cell lung cancer: Vindesine for Vinorelbine?de Cremoux, H. / Monnet, I. / Azli, N. / Voisin, S. / Ruffie, P. / Vergnes, L. / Huet, J. / Saltiel, J. C. / Armand, J. P. / Cvitkovic, E. et al. | 1994
- 362
-
Preoperative chemotherapy in non-small cell lung cancer (NSCLC) - A pilot studyFischer, J. R. / Manegold, C. / Branscheid, D. / Vogt-Moykopf, I. / Drings, P. et al. | 1994
- 366
-
Neo-Adjuvant Cisplatin and Etoposide for stage IIIA (clinical N2) non-small cell lung cancerDarwish, S. / Minotti, V. / Rossetti, R. / Ciccarese, G. / Crino, L. / Fiaschini, P. / Mercati, U. / Maranzano, E. / Latini, P. / Tonato, M. et al. | 1994
- 370
-
Concomitant chemoradiotherapy with Cisplatin dose escalation as palliative therapy for advanced malignancies of the chestDrinkard, C. L. / Haraf, J. D. / Hoffman, C. P. / Golomb, M. H. / Ferguson, K. M. / Vogelzang, J. N. / Vokes, E. E. et al. | 1994
- 375
-
Concomitant chemoradiotherapy for inoperable non-small cell carcinoma of the lung: results of continuous infusion Cisplatin in 85 patientsReboul, F. / Vincent, P. / Chauvet, B. / Brewer, Y. / Faure, C. F. / Taulelle, M. et al. | 1994
- 377
-
Late results of Neo-Adjuvant chemoradiotherapy for primary inoperable non-small cell lung cancerRebischung, J. L. / Vannetzel, J. M. / Dartevelle, P. et al. | 1994
- 383
-
Conservative treatment of esophagus cancer concomitant chemoradiotherapy treatment. First results of a 143 patients serialJacob, J. H. / Roussel, A. / Ollivier, J. M. / Izard, J. P. / Vernhes, J. C. et al. | 1994
- 386
-
Induction chemotherapy, surgery and concomitant chemoradiotherapy for carcinoma of the esophagusHoffman, P. C. / Ferguson, M. K. / Haraf, D. J. / Drinkard, L. C. / Golomb, H. M. / Vokes, E. E. et al. | 1994
- 389
-
Superiority of combined chemoradiotherapy to radiotherapy alone in patients with esophageal cancers. An intergroup studyAl-Sarraf, M. / Martz, K. / Herskovic, A. / Leichman, L. / Brindle, J. S. / Vaitkevicius, V. K. / Cooper, J. / Byhardt, R. / Davis, L. / Emami, B. et al. | 1994
- 393
-
Neo-Adjuvant chemoradiotherapy for advanced gastric cancer: a pilot study with angiotensin II induced drug delivery systemSugiyama, K. / Sato, H. / Hoshi, M. / Urushiyama, M. / Ishizuka, K. / Kanamaru, R. et al. | 1994
- 396
-
Combination of 5-FU, Leucovorin and Cisplatin (CDDP): an efficient low-toxic chemotherapy in advanced gastric adenocarcinomaYchou, M. / Fedkovic, Y. / Christopoulou, A. / Saint-Aubert, B. / Rouanet, P. / Astre, C. / Pujol, H. et al. | 1994
- 399
-
Adjuvant chemotherapy and radiotherapy in liver transplantation for primary hepatocellular carcicoma: a feasibility studyPierga, J.-Y. / Pied-bois, P. / Cherqui, D. / Duvoux, C. / Ramouni, A. / Metreau, J.-M. / Mathieu, D. / Julien, M. / Dhumeaux, D. / Fagniez, P.-L. et al. | 1994
- 405
-
Intensive weekly chemotherapy for advanced gastric cancer using 5-Fluorouracil, Cisplatin, Epirubicin, 6S-Leucovorin and Granulocyte-colony stimulating factorCascinu, S. / Fedeli, A. / Fedeli, S. L. / Catalano, G. et al. | 1994
- 411
-
Neo-Adjuvant chemotherapy for inoperable gastric cancer via local and general delivery routes (FLEP Therapy)Nakajima, T. / Ishihara, S. / Motohashi, H. / Kitamura, Y. / Nakajima, Y. / Fujii, M. / Tokunaga, A. / Matai, K. / Anzai, H. / Nishi, M. et al. | 1994
- 414
-
Gastric cancer - a place for preoperative induction regional chemotherapyStorey, B. Y. D. W. / Gallagher, P. J. / Waugh, R. C. / Stephens, F. O. et al. | 1994
- 419
-
alpha-2b-Interferon (IFN) plus chemotherapy in inoperable biliary-tract carcinoma, preliminary dataFrasci, G. / Monaco, M. / Cremone, L. / Sapio, U. / Faiella, F. / Persico, G. et al. | 1994
- 422
-
A phase II study of weekly 48 hours infusion with high-dose Fluorouracil (FU) in colorectal cancerAranda, E. / Diaz-Rubio, E. / Camps, C. / Fernandez-Marto, C. / Carrato, A. / Anton, A. / Cervantes, A. / Cruz-Hernandez, J. J. / Tres, A. / Belon, J. et al. | 1994
- 428
-
Phase II trial of Fluorouracil, Leucovorin and Interferon-alphaBukowski, R. M. / Gibson, V. / Murthy, S. / McLain, D. / Olencki, T. / Budd, G. T. et al. | 1994
- 433
-
Continuous simultaneous intra-arterial and intravenous therapy of liver metastases of colorectal carcinoma. Results of a prospective randomized studySafi, F. / Link, K. H. / Beger, H. G. et al. | 1994
- 441
-
D-Verapamil and Adriamycin in the treatment of advanced colorectal cancerScheithauer, W. / Kornek, G. / Globitz, S. / Raderer, M. / Schenk, T. / Muller, C. H. / Tetzner, C. H. et al. | 1994
- 444
-
Perioperative multimodal treatment of locally advanced rectal cancer. Results of a pilot studySchoffski, P. / Raab, H. R. / Wildfang, I. / Kohne-Wompner, C. H. / Karstens, J. H. / Pichlmayr, R. / Schmoll, H. J. et al. | 1994
- 453
-
Neo-Adjuvant chemotherapy for advanced ovarian cancerShimizu, Y. / Umezawa, S. / Takeshima, N. / Kato, T. / Hasumi, K. et al. | 1994
- 460
-
Hyperfractionation using weekly Cisplatin, Cyclophosphamide and Adriamycin (CAP) in advanced epithelial tumors of the ovaryTonkin, K. / Levin, L. et al. | 1994
- 464
-
Adjuvant treatment of ovarian carcinomaVergote, I. B. / Trope, C. G. / De Vos, L. N. / Kaern, J. / Abeler, W. M. / Winderen, M. / Pettersen, E. O. et al. | 1994
- 469
-
Cyclophosphamide (CTX) and high-dose 4-Epidoxorubicin (EPI) in advanced ovarian cancer (OC) treatmentCartei, G. / Signor, M. / Vigevani, E. / Giovannoni, M. / Sibau, A. / Clocchiatti, G. / Mansutti, M. et al. | 1994
- 473
-
High-dose chemotherapy (HDC) and autologous bone marrow transplant (ABMT) in 39 advanced ovarian cancers: long-term resultsLegros, A. / Cure, H. / Fleury, J. / Suzanne, F. / Dauplat, J. / Chollet, P. / Plagne, R. et al. | 1994
- 476
-
Concomitant chemotherapy and radiotherapy in the treatment of advanced cervix carcinomasResbeut, M. / Noirclero, M. / Gravis, G. / d Ercole, C. / Pechikoff, P. / Houvenaeghel, G. / Delpero, J. R. / Blache, J. L. / Viens, P. et al. | 1994
- 479
-
Adjuvant chemotherapies for small cell carcinoma of the uterine cervixChang, T. C. / Chang, H. C. / Lai, C. H. / Hsueh, S. / Huang, S. F. / Chang, H. K. / Soong, Y. K. et al. | 1994
- 482
-
Neo-Adjuvant M-VAC (Methotrexate, Vinblastine, Doxorubicin, Cisplatin) chemotherapy for locally advanced or metastatic cervical and vaginal cancerGarton, G. R. / Wilson, T. O. / Hartmann, L. C. / Long, H. J. / Podratz, K. C. et al. | 1994
- 485
-
A phase II trial of Neo-Adjuvant chemotherapy (CT) with Ifosfamide (I), Mesna and Cisplatinum (C) in stage IIA-IIIB cervical cancerErazo, A. / Torrecillas, L. / Cervantes, G. / Ortega, B. et al. | 1994
- 488
-
Bleomycin, Ifosfamide and Carboplatin in advanced uterine cervix carcinoma: preliminary resultsLouvet, C. / Moreau, S. / de Gramont, A. / Varette, C. / Demuynck, B. / Beerblock, K. / Marpeau, L. / Zylberait, D. / Pigne, A. / Soubrane, D. et al. | 1994
- 495
-
Surveillance in stage I non-seminomatous germ cell tumors of the testis (NSGCTT). Experience at the Instituto Nacional de Cancerologia of MexicoZinser, J. W. / Gaona, R. / Mendoza, A. / Ocampo, O. / Dominguez, H. / Vicencio, L. et al. | 1994
- 499
-
Combination chemotherapy with Etoposide, Cisplatin, Bleomycin and Cyclophosphamide for advanced metastatic non-seminomatous germ cell tumorsGerl, A. / Clemm, C. / Hentrich, M. / Hartenstein, R. / Kohl, P. / Wilmanns, W. et al. | 1994
- 503
-
Extended resection after primary chemotherapy for residual malignant non-seminomatous germ cell tumors of the mediastinum: is it worthwhile?Macchiarini, P. / Dulmet, E. / de Montpreville, V. / Chapelier, A. / Lenot, B. / Cerrina, J. / Dartevelle, P. et al. | 1994
- 510
-
The prediction of treatment outcomes in non-seminomatous extragonadal germ cell tumors (NSEGCT) by using different criteria of << poor >> and << good >> riskDelgado, F. G. / Garin, A. / Tjulandin, S. / Mendoza, M. R. / Khlebnov, A. et al. | 1994
- 513
-
Advanced seminoma treated with chemotherapy (CT)Zinser, J. W. / Gaona, R. / Mendoza, A. / Ocampo, O. / Dominguez-Malagon, H. / Gomez, E. / Vicencio, L. et al. | 1994
- 516
-
Concomitant 5-FU-CDDP and bifractioned split course radiation therapy for invasive bladder cancerMaulard, C. / Housset, M. / Chretien, Y. / Delanian, S. / Colardelle, F. / Hallez, J. P. / Dufour, B. / Baillet, F. et al. | 1994
- 520
-
Neo-Adjuvant treatment for locally advanced bladder cancer: a randomized prospective clinical trialPellegrini, A. / Cortesi, E. / Gioacchini, N. / Ballatori, E. / Virdis, R. A. et al. | 1994
- 523
-
Ultrastructural and clinical study of the urothelium after Interferon-alpha-2b treatmentStravoravdi, P. / Belivanis, J. / Dimopoulos, T. / Hatzigianis, J. / Polyzonis, M. et al. | 1994
- 527
-
Chemoradiotherapy in locally advanced bladder cancer: Neo-Adjuvant and definitive treatmentCanobbio, L. / Boccardo, F. / Curotto, A. / Pace, M. / Guarneri, D. / Rubagotti, A. / Venturini, M. / Orsatti, M. / Vitale, V. / Schenone, M. et al. | 1994
- 535
-
Interferon-alpha (IFN-alpha) combined with 5-Fluorouracil (5-FU) is an active regimen in metastatic renal cell cancerSella, A. / Finn, L. / Amato, R. / Logothetis, C. et al. | 1994
- 540
-
Comparative efficacy of hormonal therapy used alone or in combination for treatment of prostatic carcinomaMulloy, W. et al. | 1994
- 542
-
Etoposide in treatment of hormone refractory advanced carcinoma of the prostateDaneshgari, M. D. F. / Crawford, E. D. / Suzan, B. A. / Majeski, A. et al. | 1994
- 548
-
Sequential therapy with recombinant Interleukin-2 (rIL-2) and alpha-Interferon (IFN) for advanced renal cell cancer (rcc): a preliminary reportBesana, C. / Bucci, E. / Borri, A. / Schoenheit, A. / Citterio, G. / Matteucci, P. / Tognella, S. / Baiocchi, C. / Landonio, G. / Ghislandi, E. et al. | 1994
- 551
-
No advantage for the use of an early high-dose chemotherapy with autologous bone marrow transplantation in first-line treatment of poor risk non-seminomatous germ cell tumorsCure, H. / Droz, J. P. / Pico, J. L. / Biron, P. / Kerbrat, P. / Chevreau, C. / Heron, J. F. / Chevallier, B. / Fargeot, P. / Bouzy, J. et al. | 1994
- 557
-
Initial experience with autologous transplantation of 7 days noncryopreserved peripheral blood stem cells, mobilized with G-CSF, in rhabdomyosarcomaSobrevilla-Calvo, P. / Reynoso-Gomez, E. / de la Garza-Salazar, J. et al. | 1994
- 561
-
High-dose chemotherapy with granulocyte colony-stimulating factor in advanced and/or metastatic soft tissue sarcomasToma, S. / Palumbo, R. / Folco, U. / Canavese, G. / Aitini, E. / Cantoni, E. / Vincenti, M. / Rosso, R. et al. | 1994
- 565
-
Treatment of osteosarcoma with Cisplatin and Doxorubicin either as Adjuvant or Neo-Adjuvant chemotherapyZinser, J. W. / Castaneda, N. / Alfeiran, A. / Maafs, E. / Duran, M. / Flores, G. / Gaona, R. / Vicencio, L. et al. | 1994
- 568
-
The role of preoperative and Adjuvant chemotherapy in the treatment on non rhabdomyosarcoma soft tissue sarcoma in children and adolescentsGross-Wieltsch, U. / Morgan, M. / Koscielniak, E. / Treuner, J. et al. | 1994
- 573
-
Escalating doses of Epirubicin in combination with Ifosfamide and GM-CSF in previously untreated soft tissue sarcoma patients; a phase I-II studyFrustaci, S. / Buonadonna, A. / Favaro, D. / Santarosa, M. / Latini, F. / Lamon, S. / Galligioni, E. / Monfardini, S. et al. | 1994
- 577
-
Primary chemotherapy in malignant fibrous histiocytoma of bone - Updated UTMD Anderson Cancer Center ExperiencePatel, S. R. / Armen, T. / Carrasco, C. H. / Raymond, A. K. / Ayala, A. G. / Murray, J. A. / Chawla, S. P. / Benjamin, R. S. et al. | 1994
- 581
-
Concomitant radiation-Doxorubicin administration in locally advanced and/or metastatic soft tissue sarcomasToma, S. / Palumbo, R. / Grimaldi, A. / Barra, S. / Canavese, G. / Castagneto, B. / Frola, C. / Aitini, E. / Rosso, R. et al. | 1994
- 587
-
Chemotherapy as a first treatment for malignant primary CNS non-Hodgkin's lymphoma of the central nervous system (PCNSL)Boiardi, A. / Silvani, A. / Salmaggi, A. / Valentini, S. / Allegranza, A. / Broggi, G. et al. | 1994
- 590
-
Effect of six retinoids and retinoic acid catabolic inhibitor liarozole on two glioblastoma cell lines, and in vivo experience in malignant brain tumor patientsWestarp, M. E. / Westarp, M. P. / Bollag, W. / Bruynseels, J. / Biesalski, H. / Grossmann, N. / Kornhuber, H. H. et al. | 1994
- 599
-
Phase II trial with BCNU plus alpha-2B-Interferon in patients with recurrent high-grade gliomasBrandes, A. / Zampieri, P. / Rigon, A. / Scelzi, E. / Zorat, P. L. / Rotilio, A. / Amista, P. / Paccagnella, A. / Fiorentino, M. V. et al. | 1994
- 604
-
Carboplatin combined with Carmustine and Etoposide in the treatment of glioblastoma (GBM) patientsBoiardi, A. / Silvani, A. / Valentini, S. / Salmaggi, A. / Botturi, M. / Farinotti, M. / Giorgi, C. et al. | 1994
- 607
-
Phase II trial of Cystemustine, a new nitrosourea, as second-line treatment of malignant gliomasTisserant, A. / Plagne, R. / Roche, H. / Adenis, A. / Fargeot, P. / Guiochet, N. / Cattan, P. / Krakowsky, Y. / Lentz, M. A. / Fumoleau, P. et al. | 1994
- 612
-
Age effect on the survival of patients with glioblastoma and anaplastic astrocytomaHildebrand, J. / The EORTC Brain Tumour Group et al. | 1994
- 616
-
Concurrent radiochemotherapy in high-grade gliomaBrandes, A. / Zampieri, P. / Rigon, A. / Scelzi, E. / Pignatarox, M. / Berti, F. / Rotilio, A. / Padoan, A. / Amista, P. / Paccagnella, A. et al. | 1994
- 620
-
Interferon-alpha-2b + fotemustine in disseminated malignant melanomaKowalzick, L. / Mohr, P. / Weichenthal, M. / Langenbahn, H. / Hossfeld, D. K. / Breitbart, E. W. et al. | 1994
- 623
-
Tamoxifen-augmented biochemotherapy (Interferon-alpha-2b, Tamoxifen, BCNU, CDDP, DTIC) for malignant melanomaVoigt, H. / Classen, R. / Ramaker, J. et al. | 1994
- 631
-
Chemofiltration for locally advanced cancerInbar, M. / Gutman, M. / Chaitchik, S. / Klausner, J. M. et al. | 1994
- 635
-
Treatment optimization guidelines for hyperthermic antiblastic limb perfusionPace, M. / Millanta, L. / Galli, A. / Bellacci, A. et al. | 1994
- 639
-
5-FU + Folinic Acid (FA, Rescuvolin®) i.a., 5-FU + FA i.v., 5-FUDR i.a., or 5-FUDR i.a. + i.v. for treatment of non-resectable colorectal liver mestastases?Link, K. H. / Kreuser, E. D. / Safi, F. / Schalhorn, A. / Schmoll, E. / Pillasch, J. / Beger, H. G. et al. | 1994
- 649
-
Hepatic arterial chemotherapy (HAI) for unresectable liver metastases from gastrointestinal cancerMusca, F. / Esposito, R. / Toma, G. et al. | 1994
- 652
-
The treatment of presacral recurrences of rectal cancer by the use of loco-regional pelvic chemotherapy. A discussion of these methods as a Neo-Adjuvant time in locally advanced rectal tumorsManivit, P. / Polo, R. / Tabary, D. / Nabet, M. / Polo, M. / Rubini, B. / Chipponi, P. N. / Fromaget, J. M. / Untereiner, M. et al. | 1994
- 658
-
Repeated chemo-occlusion with Degradable Starch Microspheres (DSM) - Enhanced drug uptake and regional efficacy in the treatment of primary and secondary liver tumorsNilsson, B. / Johansson, C. J. / Bunke, B. / Taguchi, T. et al. | 1994
- 665
-
Antitumor efficacy of intraperitoneal hyperthermochemotherapy combined with aggressive surgery for patients with advanced gastric cancerFujimoto, S. / Takahashi, M. / Kobayashi, K. / Mutou, T. / Kure, M. / Masaoka, H. / Ohkubo, H. et al. | 1994
- 669
-
Intraperitoneal hyperthermic chemoperfusion in patients with peritoneal carcinomatosis and malignant ascitesKober, F. / Neugebauer, B. / Heiss, A. / Roka, R. et al. | 1994
- 672
-
Intra-aortic infusion chemotherapy in advanced penile carcinomaSheen, M. C. / Sheu, H. M. / CHai, C. Y. / Huang, C. H. / Wang, Y. W. et al. | 1994
- 677
-
The influence of both surgery and Adjuvant chemotherapy on breast cancer women quality of lifeCaffo, O. / Ambrosini, G. / Agugiaro, S. / Eccher, C. / Maluta, S. et al. | 1994
- 681
-
Psychological side effects induced by Interleukin-2/alpha-Interferon: clinical observations, biological correlationsSmith, M. J. / Mouawad, R. / Vuillemin, E. / Benhammouda, A. / Soubrane, C. / Khayat, D. et al. | 1994
- 691
-
Quality of life in advanced colorectal cancerFrancini, G. / Petrioli, R. / Aquino, A. / Marsili, S. / Bruni, S. / Lorenzini, L. / Mancini, S. / Lorenzi, M. / Marzocca, G. / Tani, F. et al. | 1994
- 695
-
Advance directives in the intensive care unit of a tertiary cancer centerEwer, M. S. / Taubert, J. / Ali, M. K. et al. | 1994
- 699
-
Do cancer related pain problems exist in France?Brasseur, L. / Larue, F. / Dubiez, M. / Colleau, S. / Cleeland, C. et al. | 1994
- 702
-
Intravenous granisetron-simple, safe and effective single-dose. Administration for control of chemotherapy induced nausea and vomitingDilly, S. G. et al. | 1994
- 705
-
Control of refractory nausea and vomiting with adjuvant propofol during cancer chemotherapyBorgeat, A. / Wilder-Smith, O. H. G. / Rifat, K. / Forni, M. et al. | 1994
- 707
-
Liposomal Daunorubicin treatment increases quality of life in HIV-associated Kaposi's SarcomaPresant, C. A. / Scolaro, M. / Kennedy, P. / Blayney, D. W. / Flanagan, B. / Lisak, J. / Presant, J. et al. | 1994
- 713
-
Comparison of 12 multidrug-resistance modulating agents in a model of doxorubicin-resistant rat glioblastoma cells in vitroRobert, J. / Huet, S. / Bennis, S. / Chapey, C. et al. | 1994
- 720
-
Differential formation, repair and tolerance of Cisplatin-induced DNA damage in two human small cell lung carcinoma cell linesHill, B. T. / Shellard, S. A. et al. | 1994
- 723
-
Identification of a distinctive multiple drug resistance phenotype in tumour cells following in vitro exposure to X-irradiationHill, B. T. / Whelan, R. H. D. / McClean, S. et al. | 1994
- 726
-
Functional activity of P-glycoprotein localized in subcellular structures and reversal of multidrug resistance (MDR)Toffoli, G. / Tumiotto, L. / Dall Arche, M. G. / Cernigoi, C. / Boiocchi, M. et al. | 1994
- 730
-
New strategy for the production of monoclonal antibodies to external portion of the P-glycoproteinPage, M. / Yang, X. / Roby, P. / Paradis, R. / Berkova, N. et al. | 1994
- 736
-
Myeloperoxidase is involved in Vincristine resistance in human myeloblastic leukemiaSchlaifer, D. / Cooper, M. R. / Attal, M. / Sartor, A. O. / Trepel, J. B. / Muller, C. / Laurent, G. / Myers, C. E. et al. | 1994
- 740
-
A new multidrug resistance modulating agent S 9788: preliminary report of the phase clinical trial in combination with VincristineKhayat, D. / Benhammouda, A. / Weil, M. / Vuillemin, E. / Bastian, G. / Antoine, E. / Rixe, O. / Auclerc, G. / Lucas, C. / Sarkany, M. et al. | 1994
- 745
-
Effect of Pentoxifylline, ethacrynic acid and O^6-benzyl-guanine as resistance modifiers to alkylating agents in haematological malignanciesMuller, M. R. / Schlenger, L. / Boogen, C. / Nowrousian, M. R. / Seeber, S. et al. | 1994
- 749
-
Structural alterations of human topoisomerase IIalpha responsible for drug-resistance, DNA-binding and nuclear localizationBoege, F. / Gieseler, F. / Meyer, P. et al. | 1994
- 757
-
Measurement of human tumor pharmacokinetics in vivo noninvasively by 19-F magnetic resonance spectroscopy predicts clinical 5-FU sensitivity and resistancePresant, C. A. / Wolf, W. / Waluch, V. / Brechner, R. / Wiseman, C. / Blayney, D. W. / Kennedy, P. et al. | 1994
- 759
-
Immunoregulation by tumor necrosis factor alpha (TNF): an opportunity for therapeutic intervention?Mihich, E. / Maccubbin, D. / Pocchiari, S. / Ujhazy, S. / Verstovsek, S. / Ehrke, M. J. et al. | 1994
- 765
-
Tumor necrosis factor alpha: its relationship with clinical dataLopez, J. J. B. / Escobar, M. / Gallurt, P. / Rodriguez, P. / Lorenzo, A. / Moran, A. / Senra, A. / Millan, J. et al. | 1994
- 770
-
The antiproliferative effect of lymphoblastoid alpha interferon and its ability to re-induce or amplify major histocompatibility complex antigen expression on human renal carcinoma cells in cultureAngus, R. L. / Collins, C. M. P. / Symes, M. O. et al. | 1994
- 774
-
Is there any predictive factor of the clinical response to IL-2 therapy in metastatic malignant melanoma?Soubrane, C. / Mouawad, R. / Ichen, M. / Suissa, J. / Vuillemin, E. / Borel, C. / Benhammouda, A. / Weil, M. / Khayat, D. et al. | 1994
- 779
-
How IL-2 can affect melanoma cellsPlaisance, S. / Alileche, A. / Rubinstein, E. / Han, D. / Azzarone, B. / Jasmin, C. et al. | 1994
- 785
-
Potentiation of 5-Fluorouracil-[6RS]leucovorin cytotoxicity by recombinant human Interferon-alpha2A in colon carcinoma cellsHoughton, J. A. / Adkins, D. A. / Houghton, P. J. et al. | 1994
- 789
-
Evidence for a role of immunosuppression in the pathogenesis of small cell lung cancerFischer, J. R. / Schindel, M. / Stein, N. / Lahm, H. / Gallati, H. / Drings, P. / Krammer, P. H. et al. | 1994
- 794
-
p53 expression in human soft tissue sarcomas. Correlation with biological aggressivenessToffoli, G. / Perin, T. / Doglioni, C. / Frustaci, S. / Buonadonna, A. / de Paoli, A. / Cernigoi, C. / Tumiotto, L. / Dall Arche, M. G. / Boiocchi, M. et al. | 1994
- 798
-
Synergistic cytotoxicity as an endpoint for the development of rational chemotherapeutic. Drug combinationsAbbruzzese, J. L. / Frost, P. et al. | 1994
- 804
-
5-Fluorouracil may have different mechanisms of action depending on the dose schedule: clinical implicationsAschele, C. / Sobrero, A. / Guglielmi, A. / Mori, A. / Tixi, L. / Bolli, E. / Rosso, R. / Bertino, J. R. et al. | 1994
- 809
-
Clinical studies of CPT-11 in JapanTaguchi, T. et al. | 1994
- 813
-
Evaluation of CPT-11 against human xenografts of colon adenocarcinoma and childhood sarcomasHoughton, P. J. / Hougthon, J. A. et al. | 1994
- 817
-
Microencapsulation, Tamoxifen analogues, and in vivo microscopy for tumor targetingYang, D. / Wallace, S. / Kuang, L.-R. / Li, C. / Cherif, A. / Kan, Z. / McCuskey, P. / Wright, K. C. et al. | 1994
- 820
-
A new generation of Doxorubicin-loaded liposomes with improved localization in tumors: preclinical and clinical studiesGabizon, A. / Uziely, B. / Kaufman, B. / Safra, T. / Catane, R. / Barenholz, Y. et al. | 1994
- 823
-
Degradable starch microspheres increase the cytostatic effect of the bioreductive drug RSU-1069 (aziridine 2-nitroimidazole) at arterial administration in rats with a liver carcinomaStenram, U. / Roos, G. et al. | 1994
- 826
-
Therapeutic use of polyspecific mab-labelled liposomes as carriers for radioisotopes and drugsRombi, G. / Cossu, F. / Melis, G. / Anedda, V. / Facchini, A. et al. | 1994
- 833
-
An in vitro model for neutrophil-mediated damage to tumour vasculature: effects of a novel anti-cancer agentMurray, J. C. / Smith, K. A. / Bastaki, M. / Wilson, K. B. et al. | 1994
- 838
-
Stimulation of tumor growth in-vitro and in-vivo by Suramin in an experimental modelJulieron, M. / Ramirez, L. / Bonnay, M. / Vassal, G. / Gavoille, A. / Piron, D. / Gandia, D. / Mir, L. / Munck, J.-N. et al. | 1994
- 843
-
Phase I-II trial of Seraspenide (AcSDKP): a suppressor of myelopoiesis protects against chemotherapy myelotoxicity (version 10 february 1993)Carde, P. / Goncalves, E. / Isnard, F. / de Paillette, E. D. / Chastang, C. / Mathieu-Tubiana, N. / Vuillemin, E. / Delwail, V. / Corbion, O. / Vekhoff, A. et al. | 1994
- 850
-
A review on the use of sheep epidermal squamous cell carcinoma to evaluate intra-arterial infusion chemotherapyHarker, G. J. S. / Stephens, F. O. et al. | 1994
- 855
-
Cellular and pharmacokinetic factors which influence genotoxicity of topoisomerase II inhibiting drugs in human leukemia cellsGieseler, F. / Nussler, V. / Boege, F. / Biller, D. / Meyer, P. / Willmanns, W. / Wilms, K. et al. | 1994
- 861
-
Clinical application of gene transfer in oncology: preliminary results of a French studyMerrouche, Y. / Bain, C. / Clapisson, G. / Negrier, S. / Coronel, B. / Mercatello, A. / Moskovtchenko, J.-F. / Moen, B. / Philip, T. / Favrot, M. C. et al. | 1994
- 865
-
Effects of Vitamin-A on the oestrogen dependant breast carcinoma cell line ZR75-1Horgan, P. G. / O Donoghue, J. / Byrne, J. / Phelan, C. / Given, H. F. et al. | 1994
- 871
-
Measurement of the early level of mdr1 gene expression is a predictive marker of tumour response in breast cancer patients treated by Neo-Adjuvant chemotherapyPierga, J. Y. / Chevillard, S. / Pouillart, P. / Vielh, P. et al. | 1994
- 875
-
Hematologic effects of recombinant human Interleukin-6 (rhIL-6) in sarcoma patients receiving maid chemotherapy: phase I trialBukowski, R. M. / Isaacs, R. / Gordon, M. / Demetri, G. D. / Amuels, B. / Young, D. C. / Samuel, S. / McLain, D. / Levitt, D. et al. | 1994
- 880
-
Role of G-CFS and GM-CSF in the treatment of febrile neutropenia induced by chemotherapy; preliminary results of a randomized trialRivera, F. / Mayordomo, J. I. / Diaz-Puente, M. T. / Lianes, M. P. / Lopez-Brea, M. / Lopez, E. / Paz-Ares, L. / Alonso, S. / Cortes-Funes, H. et al. | 1994
- 885
-
First line chemotherapy for patients with multiple myeloma with vad regimen followed by consolidation with high-dose chemoradiotherapy with peripheral stem cells autograft (PSCA): the experience of IGR centerBrault, P. / Gilles, E. / Ibrahim, A. / Beaujean, F. / Jimenz, S. / Tertian, G. / Hayat, M. / Bourhis, J. H. / Pico, J. L. et al. | 1994